Front page
People
Research groups
Projects
About

Suomi English

Front page
People
Research groups
Projects
About

Refine your search

Frontpage
People
Emma Aarnio

Emma Aarnio

Senior Researcher

School of Pharmacy, Faculty of Health Sciences

[email protected]

visit profile´s Research Gate page
visit profile´s Cris page
visit profile´s LinkedIn page

Information Publications

Research groups

Pharmaceutical Policy Research Group 01.01.2023 -
Pharmacoeconomics and Outcomes Research Group 01.01.2010 -
House of Effectiveness 01.11.2018 -

Projects

GuideGap: Guideline adherent prescribing and factors explaining deviations 01.01.2024 - 30.11.2027
Media visibility of medicines before marketing authorization and reimbursement 01.09.2024 - 31.12.2026
Views and experiences of users of prescription medicines, prescribers, and dispensers regarding the medicine reimbursement scheme 01.01.2026 - 30.04.2028
Center for Social and Health Care Effectiveness -project Finished 01.01.2021 - 30.09.2021

Keywords

adherence drug utilisation oral anticoagulants pharmacoeconomics pharmacoepidemiology pharmacy registers Reimbursements for medicine costs survey research

Publications

56/56 items

Biological Medicines, Biosimilars and Their Automatic Substitution: Concerns, Knowledge and Information Needs of People with Diabetes
Kouhia, Marianne; Linden, Kari; Metso, Saara; Pimiä, Elina; Koski, Sari; Aarnio, Emma; Zacheus, Tuomas; Hämeen-Anttila, Katri, 2026, Biodrugs, 40, 3, 539-551. A1 Journal article (refereed), original research
Miksi lääkehoidon seuranta ei ole riittävää? Sähköinen kysely lääkkeiden käyttäjien kokemuksista
Hovinen, Adalmiina; Timonen, Johanna; Aarnio, Emma, 2026, Sosiaalilääketieteellinen aikakauslehti, [Julkaistu 24.6.2026], 1-24. A1 Journal article (refereed), original research
Rheumatology nurses’ perspectives of automatic substitution of biological medicines in community pharmacies and its safety: a qualitative study
Oikarinen, R; Aarnio, E; Tolonen, HM; Härkänen, M; Hämeen-Anttila, K, 2026, Bmc health services research, 26, 1048. A1 Journal article (refereed), original research
Cardiovascular and glucose-lowering medication use among older adults: results from 9-year follow-up of the FINGER trial
Sääskilahti, Maria; Aarnio, Emma; Levälahti, Esko; Lehtisalo, Jenni; Kivipelto, Miia; Strandberg, Timo; Antikainen, Riitta; Soininen, Hilkka; Laatikainen, Tiina; Tuomilehto, Jaakko; Solomon, Alina; Mangialasche, Francesca; Ngandu, Tiia, 2025, European geriatric medicine, 17, 2, 961-973. A1 Journal article (refereed), original research
Expectations regarding prescription renewal and factors associated with them—a nationwide survey of medicine users
Korri, Mirka; Timonen, Johanna; Saastamoinen, Leena; Aarnio, Emma, 2025, Journal of pharmaceutical health services research, 16, 4, 1-10. A1 Journal article (refereed), original research
Kansallinen kyselytutkimus tulehduksellista suolistosairautta ja psoriaasia sairastavien näkemyksistä biosimilaareista ja biologisten lääkkeiden lääkevaihdosta
Lehtinen, Essi; Aarnio, Emma; Linden, Kari; Timonen, Johanna; Hämeen-Anttila, Katri, 2025, Dosis, 41, 3, 320-343. A1 Journal article (refereed), original research
Medication-related burden variation across chronic conditions: a population-based cross-sectional survey
Mikkola, Heidi; Aarnio, Emma; Hämeen-Anttila, Katri; Airaksinen, Marja; Dimitrow, Maarit; Saastamoinen, Leena, 2025, Bmc health services research, 25, 1, 1283. A1 Journal article (refereed), original research
Patient knowledge and acceptance of the upcoming automatic substitution of biological medicines in community pharmacies: survey of Finnish patients with inflammatory bowel disease and psoriasis
Alanne, Essi Elisabeth; Aarnio, Emma; Linden, Kari; Timonen, Johanna; Hämeen-Anttila, Katri, 2025, Bmc health services research, 25, 905. A1 Journal article (refereed), original research
Barriers and Unmet Educational Needs Regarding Implementation of Medication Adherence Management Across Europe: Insights from COST Action ENABLE
Hafez, Gaye; Aarnio, Emma; Mucherino, Sara; Kamusheva, Maria; Qvarnström, Miriam; Potočnjak, Ines; Trečiokiene, Indre; Mihajlović, Jovan; Ekenberg, Marie; van Boven, Job F M; Leiva-Fernández, Francisca; European Network to Advance Best Practices Technology on Medication AdherencE (ENABLE), 2024, Journal of general internal medicine, 39, 15, 2917-2926. A1 Journal article (refereed), original research
Lääkekorvauksiin liittyvät selvitystyöt ja niiden vaikutukset apteekeissa – pilottitutkimus apteekin farmaseuttiselle henkilöstölle
Yli-Ilkka, Elisa; Kauppinen, Hanna; Aarnio, Emma, 2024, Dosis, 40, 2, 114-132. A1 Journal article (refereed), original research
Lääkkeiden käyttäjien kokemukset lääkehoidon ongelmista ja näkemykset seurannan vastuista
Mutanen, Saana; Aarnio, Emma; Rönngård-Jalkanen, Agnese; Timonen, Johanna, 2024, Sosiaalilääketieteellinen aikakauslehti, 61, 4, 517-540. A1 Journal article (refereed), original research
Non-persistence with multiple secondary prevention medications for peripheral arterial disease among older hypertensive patients
Wawruch, Martin; Petrova, Miriam; Celovska, Denisa; Alfian, Sofa D; Tesar, Tomas; Murin, Jan; Trnka, Michal; Paduch, Tomas; Aarnio, Emma, 2024, Frontiers in pharmacology, 15, 1464689. A1 Journal article (refereed), original research
Oraalinen antikoagulaatiohoito eteisvärinäpotilailla: tromboemboliset komplikaatiot, vuototapahtumat ja kuolleisuus
Korhonen, Maarit J; Aarnio, Emma; Huupponen, Risto, 2024, Dosis, 40, 1, 28-45. A1 Journal article (refereed), original research
Pan-European survey on medication adherence management by healthcare professionals
Kamusheva, Maria; Aarnio, Emma; Qvarnström, Miriam; Hafez, Gaye; Mucherino, Sara; Potočnjak, Ines; Trečiokiene, Indre; Mihajlović, Jovan; Ekenberg, Marie; van Boven, Job FM; Leiva-Fernandez, Francisca; European Network to Advance Best Practices and Technology on Medication AdherencE (ENABLE), 2024, British journal of clinical pharmacology, 90, 12, 3135-3145. A1 Journal article (refereed), original research
Potilaiden osallisuus rationaalisen lääkehoidon tutkimuksissa – kokemuksia tutkimusryhmän potilasjäsenen merkityksestä
Hämeen-Anttila, Katri; Strömberg, Aimo; Timonen, Johanna; Aarnio, Emma, 2024, Dosis, 40, 1, 90-104. B1 Non-refereed journal articles
Register‐based study on prescription renewal without the prescriber meeting the patient
Rönngård‐Jalkanen, Agnese; Aarnio, Emma; Saastamoinen, Leena; Timonen, Johanna, 2024, Basic and clinical pharmacology and toxicology, 135, 3, 321-333. A1 Journal article (refereed), original research
Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial disease
Wawruch, Martin; Petrova, Miriam; Tesar, Tomas; Murin, Jan; Schnorrerova, Patricia; Paduchova, Martina; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Alfian, Sofa D.; Aarnio, Emma, 2023, Frontiers in pharmacology, 14, 1199669. A1 Journal article (refereed), original research
Implementation of pharmacotherapy monitoring: Experiences and views of medicine users
Rönngård-Jalkanen, Agnese; Saastamoinen, Leena; Aarnio, Emma; Timonen, Johanna, 2023, Exploratory research in clinical and social pharmacy, 12, 100377. A1 Journal article (refereed), original research
New terminology of medication adherence enabling and supporting activities: ENABLE terminology
Kardas, Przemyslaw; Aarnio, Emma; Agh, Tamas; van Boven, Job FM; Dima, Alexandra Lelia; Ghiciuc, Cristina Mihaela; Kamberi, Fatjona; Petrova, Guenka Ivanova; Nabergoj Makovec, Urska; Trečiokienė, Indrė, 2023, Frontiers in pharmacology, 14, 1254291. A1 Journal article (refereed), original research
Reimbursement and use of oral anticoagulants during 2014–2022 - A register-based study
Aarnio, Emma; Huupponen, Risto; Martikainen, Janne; Korhonen, Maarit J, 2023, Exploratory research in clinical and social pharmacy, 11, 100284. A1 Journal article (refereed), original research
Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease
Wawruch, Martin; Murin, Jan; Tesar, Tomas; Petrova, Miriam; Paduchova, Martina; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Masarykova, Lucia; Alfian, Sofa D.; Aarnio, Emma, 2023, Biomedicines, 11, 2, 368. A1 Journal article (refereed), original research
Suomalaisväestön maksuhalukkuus terveyteen liittyvästä elämänlaadusta
Hakuri, Maija; Aarnio, Emma; Martikainen, Janne; Kankaanpää, Eila, 2023, Sosiaalilääketieteellinen aikakauslehti, 60, 3, 276–288. A1 Journal article (refereed), original research
Värikäs vuosikymmen: Itä-Suomen yliopiston farmasian laitos 50 vuotta
Ranta, Veli-Pekka; Kaltiala, Ulla; Kauppinen, Hanna; Aarnio, Emma; Raunio, Hannu; Räsänen, Paula; Tiihonen, Päivi; Veki, Jaana; Siitonen, Piia, 2023, Itä-Suomen yliopisto. E3 Edited popular book
Data-driven long-term glycaemic control trajectories and their associated health and economic outcomes in Finnish patients with incident type 2 diabetes
Lavikainen, Piia; Aarnio, Emma; Linna, Miika; Jalkanen, Kari; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne, 2022, PLoS ONE, 17, 6, e0269245. A1 Journal article (refereed), original research
Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease
Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Masarykova, Lucia; Alfian, Sofa D.; Aarnio, Emma, 2022, Biomedicines, 10, 7, 1479. A1 Journal article (refereed), original research
Muutokset tyypin 2 diabetespotilaiden maksamissa lääkkeiden omavastuissa vuoden 2017 lääkekorvausmuutoksen jälkee
Parkkila, Ville; Lavikainen, Piia; Martikainen, Janne; Aarnio, Emma, 2022, Dosis, 38, 2, 214–234. A1 Journal article (refereed), original research
Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study
Ágh, Tamás; Hadžiabdić, Maja Ortner; Garuoliene, Kristina; Granas, Anne Gerd; Aarnio, Emma; Menditto, Enrica; Gregório, João; Barnestein-Fonseca, Pilar; Mevsim, Vildan; Kardas, Przemysław, 2022, Frontiers in pharmacology, 13, 892240. A1 Journal article (refereed), original research
Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease
Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Matalova, Petra; Havelkova, Beata; Trnka, Michal; Aarnio, Emma, 2021, Biomedicines, 9, 12, 1800. A1 Journal article (refereed), original research
Comparison of Communication Channels for Large-Scale Type 2 Diabetes Risk Screening and Intervention Recruitment: Empirical Study
Jalkanen, Kari; Järvenpää, Riia; Tilles-Tirkkonen, Tanja; Martikainen, Janne; Aarnio, Emma; Männikkö, Reija; Rantala, Eeva; Karhunen, Leila; Kolehmainen, Marjukka; Harjumaa, Marja; Poutanen, Kaisa; Ermes, Miikka; Absetz, Pilvikki; Schwab, Ursula; Lakka, Timo; Pihlajamäki, Jussi; Lindström, Jaana; The StopDia Study Group, 2021, JMIR diabetes, 6, 3, e21356. A1 Journal article (refereed), original research
Insuliinihoidon aloittamisen ajankohta ja perusteet tyypin 2 diabetekseen sairastuneilla
Ojala, Oona; Aarnio, Emma; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne; Lavikainen, Piia, 2021, Lääkärilehti, 76, 1-2, 48-52. A1 Journal article (refereed), original research
Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease
Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Aarnio, Emma, 2021, Frontiers in pharmacology, 12, 687549. A1 Journal article (refereed), original research
Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis
Jalkanen, Kari; Aarnio, Emma; Lavikainen, Piia; Lindström, Jaana; Peltonen, Markku; Laatikainen, Tiina; Martikainen, Janne, 2021, Bmc health services research, 21, 1, 916. A1 Journal article (refereed), original research
Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease
Wawruch, Martin; Murin, Jan; Tesar, Tomas; Paduchova, Martina; Petrova, Miriam; Celovska, Denisa; Havelkova, Beata; Trnka, Michal; Aarnio, Emma, 2021, Biomedicines, 9, 9, 1280. A1 Journal article (refereed), original research
Uusien lääkkeiden käytön ja hoitotulosten seuranta sairaaloissa
Härkönen, Ulla; Rannanheimo, Piia; Leppänen, Laura; Aarnio, Emma, 2021, Sic!, 3/2021, 5 s,. D1 Article in a trade journal
Vaikuttavuuden vuosikymmentä rakentamassa : Kansallinen sosiaali- ja terveydenhuollon vaikuttavuuskeskus -selvitys
Torkki, Paulus; Mäki-Opas, Tomi; Vanhala, Antero; Auvinen, Terhi; Aarnio, Emma; Pitkänen, Laura; Linnosmaa, Ismo; Leskelä, Riikka-Leena; Paronen, Elsa; Malmivaara, Antti; Lammintakanen, Johanna; Martikainen, Janne; Heiskanen, Jari, 2021, Helsingin yliopisto; Itä-Suomen yliopisto. D4 Published development or research report or study
Factors Associated With Reinitiation of Statin Treatment in Older Patients With Peripheral Arterial Disease
Wawruch, Martin; Wimmer Jr, Gejza; Murin, Jan; Paduchova, Martina; Tesar, Tomas; Hlinkova, Lubica; Slavkovsky, Peter; Aarnio, Emma, 2020, Drugs and aging, 37, 8, 595-604. A1 Journal article (refereed), original research
First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research
Aarnio, Emma; Huupponen, Risto; Martikainen, Jaana E; Korhonen, Maarit J, 2020, Research in social and administrative pharmacy, 16, 4, 553-559. A1 Journal article (refereed), original research
Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes
Lavikainen, Piia; Aarnio, Emma; Jalkanen, Kari; Tirkkonen, Hilkka; Rautiainen, Päivi; Laatikainen, Tiina; Martikainen, Janne, 2020, Bmc health services research, 20, 1095. A1 Journal article (refereed), original research
Non-Adherence to Statin Treatment in Older Patients with Peripheral Arterial Disease Depending on Persistence Status
Wawruch, Martin; Wimmer, Gejza Jr; Murin, Jan; Paduchova, Martina; Petrova, Miriam; Tesar, Tomas; Matalova, Petra; Havelkova, Beata; Trnka, Michal; Aarnio, Emma, 2020, Biomedicines, 8, 10, 378. A1 Journal article (refereed), original research
Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes
Lavikainen, Piia; Aarnio, Emma; Niskanen, Leo; Mäntyselkä, Pekka; Martikainen, Janne, 2020, Health policy, 124, 12, 1310-1316. A1 Journal article (refereed), original research
Use and non-use of a nationwide patient portal - a survey among pharmacy customers
Sääskilahti, Maria; Aarnio, Emma; Lämsä, Elina; Ahonen, Riitta; Timonen, Johanna, 2020, Journal of pharmaceutical health services research, 11, 4, 335-342. A1 Journal article (refereed), original research
Eight-year trajectories of changes in health-related quality of life in knee osteoarthritis: Data from the Osteoarthritis Initiative (OAI).
Törmälehto, S; Aarnio, E; Mononen, ME; Arokoski, JPA; Korhonen, RK; Martikainen, JA, 2019, PLoS ONE, 14, 7, e0219902. A1 Journal article (refereed), original research
Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population
Jalkanen, K; Aarnio, E; Lavikainen, P; Jauhonen, HM; Enlund, H; Martikainen, J, 2019, Health and quality of life outcomes, 17, 117. A1 Journal article (refereed), original research
Methodological Considerations in Pharmacoepidemiology and Pharmacovigilance Studies
Koponen, Marjaana; Ilomäki, Jenni; Aarnio, Emma; Taipale, Heidi, 2019, Babar, Zaheer-Ud-Din, Encyclopedia of Pharmacy Practice and Clinical Pharmacy. Volume 2, 435-444. D2 Article in a professional book (incl. an introduction by the editor)
Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease
Wawruch M; Wimmer G Jr; Murin J; Paduchova M; Tesar T; Hlinkova L; Slavkovsky P; Fabryova L; Aarnio E, 2019, Drugs and aging, 36, 9, 863-873. A1 Journal article (refereed), original research
The effects of reimbursement reform of antidiabetic medicines from the patients' perspective - a survey among patients with type 2 diabetes in Finland
Suviranta, T; Timonen, J; Martikainen, J; Aarnio, E, 2019, Bmc health services research, 19, 769. A1 Journal article (refereed), original research
Health-related quality of life in relation to symptomatic and radiographic definitions of knee osteoarthritis: data from Osteoarthritis Initiative (OAI) 4-year follow-up study
Törmälehto, Soili; Mononen, Mika E; Aarnio, Emma; Arokoski, Jari P A; Korhonen, Rami K; Martikainen, Janne, 2018, Health and quality of life outcomes, 16, 154. A1 Journal article (refereed), original research
Physicians' views on patient participation in choice of oral anticoagulants in atrial fibrillation - a qualitative study
Aarnio, Emma; Huupponen, Risto; Hämeen-Anttila, Katri; Merikoski, Merja; Puhakka, Jaana; Korhonen, Maarit J, 2018, Basic and clinical pharmacology and toxicology, 2019; 124, 4, 416-422. A1 Journal article (refereed), original research
Statin adherence and its effect on cost-effectiveness in the prevention of cardiovascular events
Aarnio Emma, 2017, Publications of the University of Eastern Finland. Dissertations in Health Sciences. G5 Doctoral dissertation (article)
Lääkehoitoon sitoutumisella on merkittäviä yhteiskunnallisia vaikutuksia [Teemat: Järkevä lääkehoito]
Aarnio Emma, Martikainen Janne, 2016, Sic!, 6, 1, 48-49. D1 Article in a trade journal
Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?
Aarnio Emma, Martikainen Janne, Winn Aaron N, Huupponen Risto, Vahtera Jussi, Korhonen Maarit J, 2016, Circulation: cardiovascular quality and outcomes, 9, 6, 704-713. A1 Journal article (refereed), original research
Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence - Estimates from the Finnish prescription register
Aarnio Emma, Korhonen Maarit J, Huupponen Risto, Martikainen Janne, 2015, Atherosclerosis, 239, 1, 240-247. A1 Journal article (refereed), original research
Measurement of statin exposure in the absence of information on prescribed doses
Romppainen Tomi, Rikala Maria, Aarnio Emma, Korhonen Maarit J, Saastamoinen Leena K, Huupponen Risto, 2014, European journal of clinical pharmacology, 70, 1275-1276. A1 Journal article (refereed), original research
Sequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events
Helin-Salmivaara Arja, Lavikainen Piia, Aarnio Emma, Huupponen Risto, Korhonen Maarit J, 2014, PLoS ONE, 9, e90325. A1 Journal article (refereed), original research
Register-based predictors of adherence among new statin users in Finland
Aarnio Emma J, Martikainen Janne A, Helin-Salmivaara Arja, Huupponen Risto K, Hartikainen Juha E.K, Peura Piia K, Korhonen Maarit J, 2013, Journal of clinical lipidology, 2014:8, 117-125. A1 Journal article (refereed), original research
Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial
Purmonen Timo, Pänkäläinen Emma, Turunen Juha, Asseburg Christian, Martikainen Janne, 2011, Acta oncologica, 50, 344 - 352. A1 Journal article (refereed), original research

University of Eastern Finland Joensuu, Kuopio © University of Eastern Finland

Facebook Instagram YouTube LinkedIn Snapchat SoundCloud TikTok Vimeo

Accessibility statement
Cookie usage
Give feedback

Manage consent

We use cookies to optimize our website and our service.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Asetukset Asetukset

Tekninen tallennus tai pääsy on tarpeen laillisessa tarkoituksessa sellaisten asetusten tallentamiseen, joita tilaaja tai käyttäjä ei ole pyytänyt.

Statistics Statistics

The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. Tekninen tallennus tai pääsy, jota käytetään yksinomaan anonyymeihin tilastollisiin tarkoituksiin. Ilman haastetta, Internet-palveluntarjoajasi vapaaehtoista suostumusta tai kolmannen osapuolen lisätietueita pelkästään tähän tarkoitukseen tallennettuja tai haettuja tietoja ei yleensä voida käyttää tunnistamaan sinua.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

Show preferences

{title}
{title}
{title}

Refine your search

Emma Aarnio

Research groups

Projects

Keywords

Biological Medicines, Biosimilars and Their Automatic Substitution: Concerns, Knowledge and Information Needs of People with Diabetes

Miksi lääkehoidon seuranta ei ole riittävää? Sähköinen kysely lääkkeiden käyttäjien kokemuksista

Rheumatology nurses’ perspectives of automatic substitution of biological medicines in community pharmacies and its safety: a qualitative study

Cardiovascular and glucose-lowering medication use among older adults: results from 9-year follow-up of the FINGER trial

Expectations regarding prescription renewal and factors associated with them—a nationwide survey of medicine users

Kansallinen kyselytutkimus tulehduksellista suolistosairautta ja psoriaasia sairastavien näkemyksistä biosimilaareista ja biologisten lääkkeiden lääkevaihdosta

Medication-related burden variation across chronic conditions: a population-based cross-sectional survey

Patient knowledge and acceptance of the upcoming automatic substitution of biological medicines in community pharmacies: survey of Finnish patients with inflammatory bowel disease and psoriasis

Barriers and Unmet Educational Needs Regarding Implementation of Medication Adherence Management Across Europe: Insights from COST Action ENABLE

Lääkekorvauksiin liittyvät selvitystyöt ja niiden vaikutukset apteekeissa – pilottitutkimus apteekin farmaseuttiselle henkilöstölle

Lääkkeiden käyttäjien kokemukset lääkehoidon ongelmista ja näkemykset seurannan vastuista

Non-persistence with multiple secondary prevention medications for peripheral arterial disease among older hypertensive patients

Oraalinen antikoagulaatiohoito eteisvärinäpotilailla: tromboemboliset komplikaatiot, vuototapahtumat ja kuolleisuus

Pan-European survey on medication adherence management by healthcare professionals

Potilaiden osallisuus rationaalisen lääkehoidon tutkimuksissa – kokemuksia tutkimusryhmän potilasjäsenen merkityksestä

Register‐based study on prescription renewal without the prescriber meeting the patient

Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial disease

Implementation of pharmacotherapy monitoring: Experiences and views of medicine users

New terminology of medication adherence enabling and supporting activities: ENABLE terminology

Reimbursement and use of oral anticoagulants during 2014–2022 - A register-based study

Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease

Suomalaisväestön maksuhalukkuus terveyteen liittyvästä elämänlaadusta

Värikäs vuosikymmen: Itä-Suomen yliopiston farmasian laitos 50 vuotta

Data-driven long-term glycaemic control trajectories and their associated health and economic outcomes in Finnish patients with incident type 2 diabetes

Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease

Muutokset tyypin 2 diabetespotilaiden maksamissa lääkkeiden omavastuissa vuoden 2017 lääkekorvausmuutoksen jälkee

Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study

Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease

Comparison of Communication Channels for Large-Scale Type 2 Diabetes Risk Screening and Intervention Recruitment: Empirical Study

Insuliinihoidon aloittamisen ajankohta ja perusteet ­ tyypin 2 diabetekseen sairastuneilla

Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease

Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis

Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease

Uusien lääkkeiden käytön ja hoitotulosten seuranta sairaaloissa

Vaikuttavuuden vuosikymmentä rakentamassa : Kansallinen sosiaali- ja terveydenhuollon vaikuttavuuskeskus -selvitys

Factors Associated With Reinitiation of Statin Treatment in Older Patients With Peripheral Arterial Disease

First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research

Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes

Non-Adherence to Statin Treatment in Older Patients with Peripheral Arterial Disease Depending on Persistence Status

Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes

Use and non-use of a nationwide patient portal - a survey among pharmacy customers

Eight-year trajectories of changes in health-related quality of life in knee osteoarthritis: Data from the Osteoarthritis Initiative (OAI).

Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population

Methodological Considerations in Pharmacoepidemiology and Pharmacovigilance Studies

Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease

The effects of reimbursement reform of antidiabetic medicines from the patients' perspective - a survey among patients with type 2 diabetes in Finland

Health-related quality of life in relation to symptomatic and radiographic definitions of knee osteoarthritis: data from Osteoarthritis Initiative (OAI) 4-year follow-up study

Physicians' views on patient participation in choice of oral anticoagulants in atrial fibrillation - a qualitative study

Statin adherence and its effect on cost-effectiveness in the prevention of cardiovascular events

Lääkehoitoon sitoutumisella on merkittäviä yhteiskunnallisia vaikutuksia [Teemat: Järkevä lääkehoito]

Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?

Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence - Estimates from the Finnish prescription register

Measurement of statin exposure in the absence of information on prescribed doses

Sequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events

Register-based predictors of adherence among new statin users in Finland

Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial

Insuliinihoidon aloittamisen ajankohta ja perusteet tyypin 2 diabetekseen sairastuneilla